San Diego-based Synteract has acquired Cu-Tech, and has established a center for dermatology development, with the aim of being a big player in dermatology clinical trials.

Synteract is a contract research organization in the business of clinical trials. New Jersey-based Cu-Tech possesses more than two decades of experience in dermatology.

So, Cu-Tech adds dermatology know-how, and positions Synteract to better address stringent clinical trial demands and conduct trials across investigational sites.

Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries.

Deal terms were not disclosed.